The Primary Care Show is supported by the pharmaceutical and med tech industries through grants, sponsorship and exhibition packages. Sponsors contribute by purchasing exhibition space and/or supporting speaker sessions, with no involvement in the planning or agenda of the meeting. Pharmaceutical companies participate only in this capacity and will be present at the event. Any sessions delivered with sponsor input will be clearly marked in the programme, and the full list of sponsors/exhibitors can be found HERE
As primary care surgery continues to expand, many practitioners find themselves working in relative isolation - and that’s exactly where ASPC makes a difference. We provide a welcoming professional ne …
Designed for both clinical and community environments, our upcoming Bleed Control PAcT Kits provide essential tools for rapid intervention in emergency situations. Developed with simplicity in mind, t …
Conversations with healthcare providers reveal that the effectiveness of a laboratory partnership is defined not by the range of tests offered, but by how well services integrate into clinical practic …
Across the UK, delays in diagnostic testing are placing increasing strain on healthcare providers. NHS diagnostic waiting lists exceeded 1.6 million pathways in 2024, with many patients waiting over s …
The way people approach their health is changing fast. According to Prenuvo's 2026 health trends report, patients increasingly seek advanced and specialty blood tests that go beyond routine panels, ev …
Wearable devices are transforming healthcare behaviour worldwide, with patients now actively tracking metrics such as heart rate variability (HRV), sleep quality, glucose trends, and recovery performa …
Alongside GP-focused sessions, the event includes The Role of Pharmacists in CVD Management at 14:55 in the Pharmacy Theatre, where the session description says it will explore the role of the pharmac …
The British Heart Foundation says that coronary heart disease kills more than twice as many women in the UK as breast cancer each year, and that more than 800,000 women in the UK are living with coron …
NHS England identifies atrial fibrillation, high blood pressure and high cholesterol as the key “ABC” conditions that drive cardiovascular risk and prevention work across the NHS (NHS England, 2026). …
New consensus guidance on GLP-1 weight-loss drugs stresses that these medications require ongoing nutrition, physical activity and behavioural support. Appetite suppression can increase risks of nutri …
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}